Home
Synteract

Synteract Market Share Analysis for May 2026

syneos health® is the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. we lead with a product development mindset, strategically blending clinical development, medical affairs and commercial capabilities to address modern market realities. together we share insights, use the latest technologies and apply advanced

Health > Biotechnology and Pharmaceuticals

Domainsynteract.com

Year Founded1995

Employees501 - 1000

Annual Revenue$75M - $100M

Synteract

Synteract (including company regionals)

synteract.com

See more website traffic and engagement information

Synteract Revenue up to May 2026 is 75M - 100M

revenue generated by Synteract top domains

Synteract top domains revenue over 3 years

Revenue for Synteract top domains

synteract.com75M - 100M

See more with Sales Intelligence

Total visits to Synteract's top domains

Understand Synteract market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Synteract's top domains

Analyze Synteract engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Synteract's top domains

See how Synteract keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Synteract top competitors by domain

Top similar sites in May 2026, ranked by their affinity

quanticate.comCompany NameQuanticateEmployees201 - 500HQUnited Kingdom, HitchinAnnual revenue$25M - $50MTotal visits29.1KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Synteract

These are the website technologies, by industry, used by Synteract top domains

Advertising (10)

Google Adsense

Conversion & Analytics (8)

Google Analytics

Marketing (7)

Google Marketing Platform

Widget (4)

reCAPTCHA

More Technologies

8

See all

News & Signals from Synteract

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSynteract partners with Amulet Capital Partners LP..In partnership with Amulet, Synteract drove significant organic growth through increased focus on its core emerging biopharma customer segment, reinforced by enhanced operational and commercial initiatives.

NewsSynteract acquires Clindata.Contract research organization (CRO), Synteract announced its acquisition of the human health biometrics business of Clindata, which will see the former company gaining access to the latter’s facilities in Bloemfontein, South Africa, and Colombo, Sri Lanka.